@EGOstinelli @OxfordPPL @UniofOxford @OxPsychiatry @Geointheworld @oremiou @Toshi_FRKW @And_Cipriani Great to see planned NMA of trials for treatment of bipolar mania. Would be 😎 to see how relative efficacy compares using (a) published literature vs (b)
@thebyrdlab @hildabast @ArthurLupia MAs using Drugs@FDA (eg by yours truly) have been used as gold std, e.g. https://t.co/6fyV4Sz0yk
A test for reporting bias in trial networks, research from the @BMC_series: http://t.co/mBSRGUx19x
Too good to be true: testing for reporting biased across a set of related trials http://t.co/O867Pf0OQB